Belite Bio Inc (BLTE) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Belite Bio Inc

    NASDAQ: BLTE · Real-Time Price · USD
    73.50
    -0.50 (-0.68%)
    At close: Oct 01, 2025, 3:59 PM
    73.50
    0.00%
    After-hours: Oct 01, 2025, 04:10 PM EDT

    Belite Bio Inc Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a n/a
    Cost of Revenue
    		 449K 399K 198K 30K
    Gross Profit
    		 -449K -399K -198K -30K
    Operating Income
    		 -40M -31.67M -12.82M -9.8M
    Interest Income
    		 3.74M 74K 23K 5K
    Pretax Income
    		 -36.14M -31.62M -12.65M -9.67M
    Net Income
    		 -36.14M -31.63M -12.65M -9.67M
    Selling & General & Admin
    		 10.06M 6.82M 3.95M 2.38M
    Research & Development
    		 29.94M 24.84M 8.87M 7.42M
    Other Expenses
    		 -449K -399K n/a n/a
    Operating Expenses
    		 39.55M 31.27M 12.82M 9.8M
    Interest Expense
    		 20K 25K 16K n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 -40M 31.67M 12.82M 9.8M
    Income Tax Expense
    		 6K 9K n/a n/a
    Shares Outstanding (Basic)
    		 30.54M 26.59M 19.98M 24.1M
    Shares Outstanding (Diluted)
    		 30.54M 26.59M 19.98M 24.1M
    EPS (Basic)
    		 -1.18 -1.19 -0.63 -0.4
    EPS (Diluted)
    		 -1.18 -1.19 -0.63 -0.4
    EBITDA
    		 -35.67M -31.53M -12.43M -9.64M
    EBIT
    		 -36.12M -31.67M -12.63M -9.67M
    Depreciation & Amortization
    		 449K 139K 198K 30K

    Add to Watchlist